Neoleukin Therapeutics (NLTX) Q1 2023 Earnings

May 8Confirmed
Aug 2022
Nov 2022
Q4 2022
Q1 2023
-0.3
-0.24
-0.18
-0.12

Details

Expected EPS
-0.12
Actual EPS
-0.2
Surprise EPS
-0.08
Surprise Percent
-66.67%

Description

⁨Neoleukin Therapeutics⁩ (⁦NLTX⁩) has reported earnings of ⁦-0.2⁩ per share for ⁦Q1 2023⁩.

0 Comments

Share your thoughts